These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8702616)

  • 21. Novel cleavage of a hammerhead ribozyme targeted to beta-amyloid peptide precursor mRNA.
    Denman R; Miller DL
    Arch Biochem Biophys; 1993 Sep; 305(2):392-400. PubMed ID: 8373177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization in vitro and in vivo of hammerhead ribozymes directed against murine tumor necrosis factoralpha.
    MacKay SL; Tannahill CL; Auffenberg T; Ksontini R; Copeland EM; Moldawer LL
    Biochem Biophys Res Commun; 1999 Jul; 260(2):390-7. PubMed ID: 10403780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hammerhead ribozyme targeting connective tissue growth factor mRNA blocks transforming growth factor-beta mediated cell proliferation.
    Blalock TD; Yuan R; Lewin AS; Schultz GS
    Exp Eye Res; 2004 Jun; 78(6):1127-36. PubMed ID: 15109919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intervention of geminiviral replication in yeast by ribozyme mediated downregulation of its Rep protein.
    Chilakamarthi U; Mukherjee SK; Deb JK
    FEBS Lett; 2007 Jun; 581(14):2675-83. PubMed ID: 17531225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and specificity of hammerhead ribozymes against calretinin mRNA.
    Ellis J; Rogers J
    Nucleic Acids Res; 1993 Nov; 21(22):5171-8. PubMed ID: 8255773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small, efficient hammerhead ribozymes.
    McCall MJ; Hendry P; Mir AA; Conaty J; Brown G; Lockett TJ
    Mol Biotechnol; 2000 Jan; 14(1):5-17. PubMed ID: 10911611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics and thermodynamics make different contributions to RNA folding in vitro and in yeast.
    Mahen EM; Harger JW; Calderon EM; Fedor MJ
    Mol Cell; 2005 Jul; 19(1):27-37. PubMed ID: 15989962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J; Breaker RR
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of a chimeric ribozyme gene results in endonucleolytic cleavage of target mRNA and a concomitant reduction of gene expression in vivo.
    Steinecke P; Herget T; Schreier PH
    EMBO J; 1992 Apr; 11(4):1525-30. PubMed ID: 1373377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of hammerhead ribozymes cleaving mdr-1 mRNA.
    Palfner K; Kneba M; Hiddemann W; Bertram J
    Biol Chem Hoppe Seyler; 1995 May; 376(5):289-95. PubMed ID: 7544982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M; Homann M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clone, expression and cleavage activity of anti-caspase-7 hammerhead ribozyme in vitro].
    Zhang W; Xie Q; Zhou XQ; Jiang S; Jin YX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):684-7. PubMed ID: 15623380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
    Li YL; Torchet C; Vergne J; Maurel MC
    Biochimie; 2007 Oct; 89(10):1257-63. PubMed ID: 17703868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
    De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
    Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial virus phi29 pRNA as a hammerhead ribozyme escort to destroy hepatitis B virus.
    Hoeprich S; Zhou Q; Guo S; Shu D; Qi G; Wang Y; Guo P
    Gene Ther; 2003 Aug; 10(15):1258-67. PubMed ID: 12858191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential activity of trans-acting hammerhead ribozymes targeted to beta amyloid peptide precursor mRNA by altering the symmetry of helices I and III.
    Denman RB; Smedman M; Kung L
    Arch Biochem Biophys; 1995 Oct; 323(1):71-8. PubMed ID: 7487076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational suppression by hammerhead ribozymes and inactive variants in S. cerevisiae.
    Yim SH; Park I; Ahn JK; Kang C
    Biomol Eng; 2000 Jun; 16(6):183-9. PubMed ID: 10894112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
    Campbell TB; McDonald CK; Hagen M
    Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.
    Vaish NK; Heaton PA; Fedorova O; Eckstein F
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2158-62. PubMed ID: 9482855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells.
    Hübinger G; Schmid M; Linortner S; Manegold A; Bergmann L; Maurer U
    Exp Hematol; 2001 Oct; 29(10):1226-35. PubMed ID: 11602325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.